High-flying Hologic splits stock

Article

Bone densitometry firm Hologic of Waltham, MA, announced a two-for-onestock split effective March 25. Hologic's share price has risensteadily since last year, when Merck received marketing approvalfor its Fosamax osteoporosis drug, and the split will

Bone densitometry firm Hologic of Waltham, MA, announced a two-for-one

stock split effective March 25. Hologic's share price has risen

steadily since last year, when Merck received marketing approval

for its Fosamax osteoporosis drug, and the split will make the

company's stock more affordable. Hologic's stock was trading at

around $50 a share the week before the split. It had been trading

at around $14 a share last March (SCAN 12/27/95).

Related Videos
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Emerging Innovations in Molecular Imaging
Related Content
© 2023 MJH Life Sciences

All rights reserved.